474943-59-4

474943-59-4 structure

Name: 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (sodium salt)
Chemical Name: Sodium (2R)-3-[(2H31)hexadecanoyloxy]-2-[(9Z)-9-octadecenoyloxy]propyl hydrogen phosphate
CAS Number: 474943-59-4
Molecular Formula: C₃₇H₃₉D₃₁NaO₈P
Molecular Weight: 728.102
Catalog: Research Areas Others
Create Date: 2018-06-21 19:31:13
Modify Date: 2024-01-20 14:49:57
16:0-18:1 PA-d31 (sodium) is deuterium labeled 16:0-18:1 PA (sodium).

Name	Sodium (2R)-3-[(2H31)hexadecanoyloxy]-2-[(9Z)-9-octadecenoyloxy]propyl hydrogen phosphate
Synonyms	Sodium (2R)-3-[(H)hexadecanoyloxy]-2-[(9Z)-9-octadecenoyloxy]propyl hydrogen phosphate 9-Octadecenoic acid, (1R)-2-[(1-oxohexadecyl-2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-d)oxy]-1-[(phosphonooxy)methyl]ethyl ester, sodium salt, (9Z)- (1:1)

Description	16:0-18:1 PA-d31 (sodium) is deuterium labeled 16:0-18:1 PA (sodium).
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.